about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin...
Read More
0.79
-0.08
(-9.20%)
69,362
XNAS Volume
High vol.+loss this week
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for BeyondSpring Inc is on 13 Aug 2026 for the purpose of BeyondSpring Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..